23 research outputs found
The Caretaker Role of ARID1A in DNA Repair and the Effects of Targeted Therapy in ARID1A Mutated Cancers
Somatic inactivating mutations in ARID1A, a component of the SWI/SNF chromatin remodeling complex, have been identified in various human malignancies, and are particularly common in tumors originating from endometrial epithelium (i.e. endometrioid adenocarcinoma of the uterus and endometriosis-associated ovarian cancers). Loss of ARID1A compromises DNA damage repair in vitro, but the underlying mechanisms and clinical relevance of these findings are unclear.
In the present study, we observed increased DNA damage in association with ARID1A-deficiency in endometrial tissues from human samples and from an inducible PAX8-driven Arid1a-deletion mouse model. Using isogenic pairs of cell lines differing only in ARID1A status, we demonstrate the indispensable role of ARID1A in establishing an open chromatin state at DNA double-strand breaks, which is necessary for the repair proteins 53BP1 and RIF1, components of the non-homologous end-joining (NHEJ) machinery, to access and repair the damage. The inability of ARID1A-/- cells to mount an NHEJ-mediated DNA repair response renders them more sensitive to irradiation than ARID1A-intact controls. Small-molecule compound screens conducted in isogenic cell lines revealed that the PARP inhibitor, Olaparib, synergizes with radiation to elicit cytotoxicity selectively in the context of ARID1A deficiency. Combination treatment with low-dose radiation and Olaparib demonstrated improved efficacy in reducing tumor growth in mouse xenograft models of ARID1A-mutant endometrial and ovarian clear cell carcinomas compared to either treatment alone, while no improvements over monotherapy were observed in mice carrying ARID1A-intact tumors. Since ARID1A functions in a âcaretakerâ role by facilitating NHEJ-mediated repair of DNA DSBs, inducing a high burden of DSBs, by combining radiation with PARP inhibition, may be a particularly efficacious strategy for the treatment of ARID1A-deficient gynecologic cancers
Novel involvement of leukotriene B4 receptor 2 through ERK activation by PP2A down-regulation in leukotriene B4-induced keratin phosphorylation and reorganization of pancreatic cancer cells
AbstractPerinuclear reorganization via phosphorylation of specific serine residues in keratin is involved in the deformability of metastatic cancer cells. The level of leukotriene B4 is high in pancreatic cancers. However, the roles of LTB4 and its cognate receptors in keratin reorganization of pancreatic cancers are not known. LTB4 dose-dependently induced phosphorylation and reorganization of Keratin 8 (K8) and these processes were reversed by LY255283 (BLT2 antagonist). BLT2 agonists such as Comp A and 15(S)-HETE also induced phosphorylation of serine 431 in K8. Moreover, Comp A-induced K8 phosphorylation and reorganization were blocked by LY255283. Gene silencing of BLT2 suppressed Comp A-induced K8 phosphorylation and reorganization in PANC-1 cells. Over-expression of BLT2 promoted K8 phosphorylation. Comp A promoted the migration of PANC-1 cells in a dose-dependent manner, and LY255283 blocked Comp A-induced migration, respectively. PD98059 (ERK inhibitor) suppressed Comp A-induced phosphorylation of serine 431 and reorganization of K8. Gene silencing of BLT2 suppressed the expression of pERK, and over-expression of BLT2 increased the expression of pERK even without Comp A. Comp A induced the expression of active ERK (pERK) and BLT2. These inductions were blocked by PD98059. Comp A decreased PP2A expression and hindered the binding of PP2A to the K8, leading to the activation of ERK. PD98059 suppressed the Comp A-induced migration of PANC-1 cells and BLT2 over-expression-induced migration of PANC-1 cells. Overall, these results suggest that BLT2 is involved in LTB4âinduced phosphorylation and reorganization through ERK activation by PP2A downregulation, leading to increased migration of PANCâ1 cells
e-Learning quality assessment in higher education: A mapping study
Quality assessment is today a success factor and a guarantee in the
implementation and development of countless initiatives, programs
and strategies in a very wide variety of fields. For this reason, in an
educational field in a constant transformation, the evaluation of the
quality of each process, phase and tool must be understood as an
essential and basic part in teaching, betting on the implementation
of quality evaluation processes in the virtual environment and also
trying to adapt reality to new learning environments. In the present
moment, in a society in which everything has to be evaluated, the
establishment of evaluation standards for new instruments and the
standardization of accepted and validated processes will also make
virtual teaching-learning environments more reliable and effective.
This research proposes a mapping study with the aim to find
out the situation in which the research on quality evaluation in
e-Learning in higher education finds itself. The criteria used for
the selection of publications are concise and the complete process
carried out is reflected in each of its phases. The results allow us to
describe the current reality in a temporal perspective and the state
of the art, in order to address the potential future lines of research
in the field of quality assessment in virtual environments
Structure of the Human TELO2-TTI1-TTI2 Complex
Phosphatidylinositol 3-kinase-related protein kinases (PIKKs) play critical roles in various metabolic pathways related to cell proliferation and survival. The TELO2-TTI1-TTI2 (TTT) complex has been proposed to recognize newly synthesized PIKKs and to deliver them to the R2TP complex (RUVBL1-RUVBL2-RPAP3-PIH1D1) and the heat shock protein 90 chaperone, thereby supporting their folding and assembly. Here, we determined the cryo-EM structure of the TTT complex at an average resolution of 4.2 angstrom. We describe the full-length structures of TTI1 and TELO2, and a partial structure of TTI2. All three proteins form elongated helical repeat structures. TTI1 provides a platform on which TELO2 and TTI2 bind to its central region and C-terminal end, respectively. The TELO2 C-terminal domain (CTD) is required for the interaction with TTI1 and recruitment of Ataxia-telangiectasia mutated (ATM). The N- and C-terminal segments of TTI1 recognize the FRAP-ATM-TRRAP (FAT) domain and the N-terminal HEAT repeats of ATM, respectively. The TELO2 CTD and TTI1 N- and C-terminal segments are required for cell survival in response to ionizing radiation. (C) 2021 Elsevier Ltd. All rights reserved
Structure of the Human TELO2-TTI1-TTI2 Complex
© 2021 Elsevier LtdPhosphatidylinositol 3-kinase-related protein kinases (PIKKs) play critical roles in various metabolic pathways related to cell proliferation and survival. The TELO2-TTI1-TTI2 (TTT) complex has been proposed to recognize newly synthesized PIKKs and to deliver them to the R2TP complex (RUVBL1-RUVBL2-RPAP3-PIH1D1) and the heat shock protein 90 chaperone, thereby supporting their folding and assembly. Here, we determined the cryo-EM structure of the TTT complex at an average resolution of 4.2 Ă
. We describe the full-length structures of TTI1 and TELO2, and a partial structure of TTI2. All three proteins form elongated helical repeat structures. TTI1 provides a platform on which TELO2 and TTI2 bind to its central region and C-terminal end, respectively. The TELO2 C-terminal domain (CTD) is required for the interaction with TTI1 and recruitment of Ataxia-telangiectasia mutated (ATM). The N- and C-terminal segments of TTI1 recognize the FRAP-ATM-TRRAP (FAT) domain and the N-terminal HEAT repeats of ATM, respectively. The TELO2 CTD and TTI1 N- and C-terminal segments are required for cell survival in response to ionizing radiation.N
Medical image segmentation automatic quality control: A multi-dimensional approach
International audienceThe main finding of the present study was that the metabolic changes associated with a moderate-intensity muscle exercise were slightly modified in stable sickle cell anemia patients and sickle cell trait carriers as compared to controls but still in the normal range. The present results strongly support the safety of a moderate-intensity exercise for stable sickle cell anemia patients and sickle cell trait carriers
Recommended from our members
Hyperpolarized NMR study of the impact of pyruvate dehydrogenase kinase inhibition on the pyruvate dehydrogenase and TCA flux in type 2 diabetic rat muscle.
The role of pyruvate dehydrogenase in mediating lipid-induced insulin resistance stands as a central question in the pathogenesis of type 2 diabetes mellitus. Many researchers have invoked the Randle hypothesis to explain the reduced glucose disposal in skeletal muscle by envisioning an elevated acetyl CoA pool arising from increased oxidation of fatty acids. Over the years, in vivo NMR studies have challenged that monolithic view. The advent of the dissolution dynamic nuclear polarization NMR technique and a unique type 2 diabetic rat model provides an opportunity to clarify. Dynamic nuclear polarization enhances dramatically the NMR signal sensitivity and allows the measurement of metabolic kinetics in vivo. Diabetic muscle has much lower pyruvate dehydrogenase activity than control muscle, as evidenced in the conversion of [1-13C]lactate and [2-13C]pyruvate to HCO3- and acetyl carnitine. The pyruvate dehydrogenase kinase inhibitor, dichloroacetate, restores rapidly the diabetic pyruvate dehydrogenase activity to control level. However, diabetic muscle has a much larger dynamic change in pyruvate dehydrogenase flux than control. The dichloroacetate-induced surge in pyruvate dehydrogenase activity produces a differential amount of acetyl carnitine but does not affect the tricarboxylic acid flux. Further studies can now proceed with the dynamic nuclear polarization approach and a unique rat model to interrogate closely the biochemical mechanism interfacing oxidative metabolism with insulin resistance and metabolic inflexibility
Characterization of a small molecule modulator of inflammatory cytokine production
Abstract In the present study, the effect(s) of the immunomodulatory drug GLS-1027 on various cell types involved in inflammation were investigated. GLS-1027 reduced LPS-stimulated secretion of pro-inflammatory cytokines by macrophage or monocytic cells and cell lines. This reduction was likely due in part to decreased activation of NF-ÎșB family transcription factors and inhibition of p38 MAPK signaling in GLS-1027-treated cells. Independent from its effects on macrophages, GLS-1027 inhibited dendritic cell maturation and differentiation of naĂŻve CD4+ T cells into Th17 cells, reducing the production of typical pro-inflammatory cytokines associated with both processes. In vivo administration of GLS-1027 prevented the development of type 1 diabetes in NOD mice which correlated with reduced serum levels of IL17A in GLS-1027 treated animals and reduced ex vivo production of IL17A from both spleen and lymph-node cells. Overall, our data show that GLS-1027 can reduce inflammation through multiple actions, including the reduction of pro-inflammatory cytokine production by innate immune cells, the inhibition of dendritic cells maturation, and the inhibition of Th17 cells polarization
Impact of diabetes and smoking on mortality in tuberculosis.
Diabetes mellitus is a risk factor for tuberculosis (TB) disease. There is evidence that diabetes also influences TB severity and treatment outcomes but information is incomplete and some published results have been inconsistent.A longitudinal cohort study was conducted at the National Masan Tuberculosis Hospital in the Republic of Korea. Subjects presenting with a first episode of TB or for retreatment of TB were followed from enrollment through completion of treatment. Demographic, clinical, and microbiological variables were recorded, along with assessment of outcomes. Results were compared in TB patients with and without diabetes or smoking history. Data were adjusted for gender, age, cohort, educational level and alcohol consumption.The combined cohorts comprised 657 subjects. Diabetes was present in 25% and was associated with greater radiographic severity and with recurrent or relapsed TB. Diabetes and cigarette smoking independently increased the risk of death in the first 12 months after enrollment. Estimating the combined impact of diabetes and smoking yielded a hazard ratio of 5.78. Only 20% of diabetic subjects were non-smokers; 54% smoked â„1 pack daily. In this cohort, the impact of diabetes on mortality was greater in patients younger than 50 years, compared to older patients.In this cohort of Korean patients, diabetes exacerbated the severity of TB disease. Diabetic subjects who smoked â„1 pack of cigarettes daily were at particularly high risk of death from TB. Strategies to improve TB outcomes could productively focus resources for patient education and TB prevention on the vulnerable population of younger diabetics, particularly those who also smoke